Penetrium Bioscience Unveils Breakthrough Mechanism Solving 137-Year-Old "Seed & Soil" Paradigm, Opening a New Era for Targeted Cancer Therapy

by | PRNewswire Asia

SEOUL, South Korea, April 17, 2026 /PRNewswire/ — Penetrium Bioscience (KOSDAQ 187660) today announced compelling new scientific evidence demonstrating, for the first time at the cellular level, the underlying mechanism behind the long-standing "Seed &...

Instant Khao Lam (Glutinous Rice in Bamboo Cylinders), a local souvenir that can now be enjoyed internationally

by | PRNewswire Asia

BANGKOK, April 16, 2026 /PRNewswire/ — A lecturer in the Department of Food Technology, Faculty of Science, Chulalongkorn University, has developed an instant version of Khao Lam (Glutinous Rice in Bamboo Cylinders), preserving...

French May Arts Festival & French GourMay 2026 Programme Lineup Revealed

by | PRNewswire Asia

Featuring Top-Tier Art, Music, Dance, Theatre, Immersive Experiences, Circus, Film and Gastronomy HONG KONG, April 16, 2026 /PRNewswire/ — French May Arts Festival ("French May") and French GourMay Food & Wine Festival ("French GourMay")...

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

by | PRNewswire Asia

Piramal Pharma Solutions is a global leader in antibody-drug conjugate (ADC) development and manufacturing, leveraging over 20 years of specialized experience to support partners from early-stage to commercialization. Ajinomoto Bio-Pharma Services is a leading...

Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice

by | PRNewswire Asia

Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026 SEOUL, South Korea, April 16, 2026 /PRNewswire/ — At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and...

Mabwell Establishes a Licensing and Commercialization Agreement for Denosumab Biosimilars in Malaysian Market

by | PRNewswire Asia

SHANGHAI, April 16, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that it has established a licensing and commercialization agreement with a strategic business partner...